{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:03:01Z","timestamp":1780938181407,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00522-3","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T05:02:05Z","timestamp":1766206925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surgery in NF2-Schwannomatosis"],"prefix":"10.1007","volume":"25","author":[{"given":"Michel","family":"Kalamarides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Pathmanaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Peyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Thomas","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"issue":"1","key":"522_CR1","doi-asserted-by":"publisher","first-page":"E98","DOI":"10.1002\/lary.28998","volume":"131","author":"PC Comes","year":"2021","unstructured":"Comes PC, Peyre M, Sanson M, Sterkers O, Bernardeschi D, Kalamarides M (2021) Current management of large vestibular schwannomas for NF2 patients in a National reference center. Laryngoscope 131(1):E98\u2013E107. https:\/\/doi.org\/10.1002\/lary.28998","journal-title":"Laryngoscope"},{"issue":"3","key":"522_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.otc.2023.02.012","volume":"56","author":"P Jiramongkolchai","year":"2023","unstructured":"Jiramongkolchai P, Schwartz MS, Friedman RA (2023) Management of neurofibromatosis type 2-Associated vestibular schwannomas. Otolaryngol Clin North Am 56(3):533\u2013541. https:\/\/doi.org\/10.1016\/j.otc.2023.02.012","journal-title":"Otolaryngol Clin North Am"},{"issue":"7","key":"522_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noaa284","volume":"23","author":"C Forde","year":"2021","unstructured":"Forde C, King AT, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SR, Pathmanaban ON, Stapleton E, Thomas OM, Laitt RD, Stivaros S, Kilday JP, Vassallo G, McBain C, Kerrigan S, Smith MJ, McCabe MG, Harkness EF, Evans DG (2021) Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution. Neuro Oncol 23(7):1113\u20131124. https:\/\/doi.org\/10.1093\/neuonc\/noaa284","journal-title":"Neuro Oncol"},{"issue":"10","key":"522_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/jmedgenet-2015-103290","volume":"52","author":"A Hexter","year":"2015","unstructured":"Hexter A, Jones A, Joe H, Heap L, Smith MJ, Wallace AJ, Halliday D, Parry A, Taylor A, Raymond L, Shaw A, Afridi S, Obholzer R, Axon P, King AT, English Specialist NF2 Research Group, Friedman JM, Evans DG (2015) Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK National analysis of 1192 patients. J Med Genet 52(10):699\u2013705. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103290","journal-title":"J Med Genet"},{"issue":"10","key":"522_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday D, Emmanouil B, Pretorius P, MacKeith S, Painter S, Tomkins H, Evans DG, Parry A (2017) Genetic severity score predicts clinical phenotype in NF2. J Med Genet 54(10):657\u2013664. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104519","journal-title":"J Med Genet"},{"issue":"1","key":"522_CR6","doi-asserted-by":"publisher","first-page":"vdad025","DOI":"10.1093\/noajnl\/vdad025","volume":"5","author":"DG Evans","year":"2023","unstructured":"Evans DG, Halliday D, Obholzer R, Afridi S, Forde C, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SM, Pathmanaban ON, Thomas OM, Laitt RD, Stivaros S, Kilday JP, Vassallo G, McBain C, Lavin T, Paterson C, Whitfield G, McCabe MG, Axon PR, Halliday J, Mackeith S, Parry A, English Specialist NF2 Research Group, Harkness EF, Buttimore J, King AT (2023) Radiation treatment of benign tumors in NF2-related-schwannomatosis: A National study of 266 irradiated patients showing a significant increase in malignancy\/malignant progression. Neurooncol Adv 5(1):vdad025. https:\/\/doi.org\/10.1093\/noajnl\/vdad025","journal-title":"Neurooncol Adv"},{"issue":"6","key":"522_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1227\/NEU.0b013e31828bae28","volume":"72","author":"M Peyre","year":"2013","unstructured":"Peyre M, Goutagny S, Bah A, Bernardeschi D, Larroque B, Sterkers O, Kalamarides M (2013) Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results. Neurosurgery 72(6):907\u2013913. https:\/\/doi.org\/10.1227\/NEU.0b013e31828bae28","journal-title":"Neurosurgery"},{"issue":"3","key":"522_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1227\/01.NEU.0000255340.26027.53","volume":"60","author":"D Mathieu","year":"2007","unstructured":"Mathieu D, Kondziolka D, Flickinger JC, Niranjan A, Williamson R, Martin JJ, Lunsford LD (2007) Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60(3):460\u2013468. https:\/\/doi.org\/10.1227\/01.NEU.0000255340.26027.53","journal-title":"Neurosurgery"},{"issue":"4","key":"522_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1056\/NEJMoa0902579","volume":"361","author":"SR Plotkin","year":"2009","unstructured":"Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E (2009) Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 361(4):358\u2013367. https:\/\/doi.org\/10.1056\/NEJMoa0902579","journal-title":"N Engl J Med"},{"issue":"2","key":"522_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11060-017-2447-3","volume":"133","author":"S Goutagny","year":"2017","unstructured":"Goutagny S, Giovannini M, Kalamarides M (2017) A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas. J Neurooncol 133(2):443\u2013445. https:\/\/doi.org\/10.1007\/s11060-017-2447-3","journal-title":"J Neurooncol"},{"issue":"24","key":"522_CR11","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa2400985","volume":"390","author":"SR Plotkin","year":"2024","unstructured":"Plotkin SR, Yohay KH, Nghiemphu PL, Dinh CT, Babovic-Vuksanovic D, Merker VL, Bakker A, Fell G, Trippa L, Blakeley JO, INTUITT-NF2 Consortium (2024) Brigatinib in NF2-Related schwannomatosis with progressive tumors. N Engl J Med 390(24):2284\u20132294. https:\/\/doi.org\/10.1056\/NEJMoa2400985","journal-title":"N Engl J Med"},{"issue":"9","key":"522_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/cancers11091376","volume":"11","author":"I Gugel","year":"2019","unstructured":"Gugel I, Grimm F, Liebsch M, Zipfel J, Teuber C, Kluwe L, Mautner VF, Tatagiba M, Schuhmann MU (2019) Impact of surgery on Long-Term results of hearing in neurofibromatosis Type-2 associated vestibular schwannomas. Cancers (Basel) 11(9):1376. https:\/\/doi.org\/10.3390\/cancers11091376","journal-title":"Cancers (Basel)"},{"issue":"3","key":"522_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/0194599817741839","volume":"158","author":"SR Best","year":"2018","unstructured":"Best SR, Ahn J, Langmead S, Dhillon V, Hillel AT, Akst LM, Blakeley JO (2018) Voice and swallowing dysfunction in neurofibromatosis 2. Otolaryngol Head Neck Surg 158(3):505\u2013510. https:\/\/doi.org\/10.1177\/0194599817741839","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"522_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/WNO.0000000000000675","volume":"39","author":"SL Painter","year":"2019","unstructured":"Painter SL, Sipkova Z, Emmanouil B, Halliday D, Parry A, Elston JS (2019) Neurofibromatosis type 2-Related eye disease correlated with genetic severity type. J Neuroophthalmol 39(1):44\u201349. https:\/\/doi.org\/10.1097\/WNO.0000000000000675","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"522_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s10143-019-01143-y","volume":"43","author":"L Troude","year":"2020","unstructured":"Troude L, Boucekine M, Montava M, Balossier A, Lavieille JP, R\u00e9gis J, Roche PH (2020) Does NF2 status impact the results of combined surgery and adjunctive gamma knife surgery for large vestibular schwannomas? Neurosurg Rev 43(4):1191\u20131199. https:\/\/doi.org\/10.1007\/s10143-019-01143-y","journal-title":"Neurosurg Rev"},{"issue":"21","key":"522_CR16","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.3390\/jcm12216906","volume":"12","author":"B Hochet","year":"2023","unstructured":"Hochet B, Daoudi H, Lefevre E, Nguyen Y, Bernat I, Sterkers O,Lahlou G, Kalamarides M (2023) Monitoring cochlear nerve action potential for hearing preservation in Medium\/Large vestibular Schwannoma surgery: tips and pitfalls. J Clin Med 12(21):6906. https:\/\/doi.org\/10.3390\/jcm12216906","journal-title":"J Clin Med"},{"issue":"4 Suppl","key":"522_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3171\/ped.2007.106.4.255","volume":"106","author":"WH Slattery","year":"2007","unstructured":"Slattery WH 3rd, Fisher LM, Hitselberger W, Friedman RA, Brackmann DE (2007) Hearing preservation surgery for neurofibromatosis type 2-related vestibular Schwannoma in pediatric patients. J Neurosurg 106(4 Suppl):255\u2013260. https:\/\/doi.org\/10.3171\/ped.2007.106.4.255","journal-title":"J Neurosurg"},{"issue":"6","key":"522_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/MAO.0b013e3182267eb7","volume":"32","author":"WH Slattery","year":"2011","unstructured":"Slattery WH, Hoa M, Bonne N, Friedman RA, Schwartz MS, Fisher LM, Brackmann DE (2011) Middle fossa decompression for hearing preservation: a review of institutional results and indications. Otol Neurotol 32(6):1017\u20131024. https:\/\/doi.org\/10.1097\/MAO.0b013e3182267eb7","journal-title":"Otol Neurotol"},{"issue":"3","key":"522_CR19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1227\/NEU.0000000000001125","volume":"79","author":"D Bernardeschi","year":"2016","unstructured":"Bernardeschi D, Peyre M, Collin M, Smail M, Sterkers O, Kalamarides M (2016) Internal auditory Canal decompression for hearing maintenance in neurofibromatosis type 2 patients. Neurosurgery 79(3):370\u2013377. https:\/\/doi.org\/10.1227\/NEU.0000000000001125","journal-title":"Neurosurgery"},{"issue":"3","key":"522_CR20","doi-asserted-by":"publisher","first-page":"E560","DOI":"10.1093\/neuros\/nyz057","volume":"85","author":"NX Bonne","year":"2019","unstructured":"Bonne NX, Risoud M, Hoa M, Lemesre PE, Aboukais R, Le Rhun E, Dubrulle F, Baroncini M, Lejeune JP, Vincent C (2019) Hearing response following internal auditory Canal decompression in neurofibromatosis type 2. Neurosurgery 85(3):E560\u2013E567. https:\/\/doi.org\/10.1093\/neuros\/nyz057","journal-title":"Neurosurgery"},{"issue":"4","key":"522_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/neuonc\/nou317","volume":"17","author":"R Dewan","year":"2015","unstructured":"Dewan R, Pemov A, Kim HJ, Morgan KL, Vasquez RA, Chittiboina P, Wang X, Chandrasekharappa SC, Ray-Chaudhury A, Butman JA, Stewart DR, Asthagiri A (2015) Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas. Neuro Oncol 17(4):566\u2013573. https:\/\/doi.org\/10.1093\/neuonc\/nou317","journal-title":"Neuro Oncol"},{"issue":"6","key":"522_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00701-019-03933-1","volume":"161","author":"SD Adib","year":"2019","unstructured":"Adib SD, Tatagiba M (2019) Surgical management of collision-tumors between vestibular Schwannoma and meningioma in the cerebellopontine angle in patients with neurofibromatosis type 2. Acta Neurochir (Wien) 161(6):1157\u20131163. https:\/\/doi.org\/10.1007\/s00701-019-03933-1","journal-title":"Acta Neurochir (Wien)"},{"key":"522_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/lary.32342","author":"CG Wood","year":"2025","unstructured":"Wood CG, Kozanno L, Stemmer-Rachamimov A, Lee DJ, Barker FG 2nd, Carter BS, Plotkin SR, Jordan JT, Chang LS, Welling DB (2025) Increased hemorrhage during excision of Bevacizumab-Treated NF2-Related vestibular schwannomas. Laryngoscope. https:\/\/doi.org\/10.1002\/lary.32342","journal-title":"Laryngoscope"},{"issue":"10","key":"522_CR24","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/neuonc\/nor101","volume":"13","author":"M Peyre","year":"2011","unstructured":"Peyre M, Goutagny S, Imbeaud S, Bozorg-Grayeli A, Felce M, Sterkers O, Kalamarides M (2011) Increased growth rate of vestibular Schwannoma after resection of contralateral tumor in neurofibromatosis type 2. Neuro Oncol 13(10):1125\u20131132. https:\/\/doi.org\/10.1093\/neuonc\/nor101","journal-title":"Neuro Oncol"},{"issue":"1","key":"522_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s00701-024-06243-3","volume":"166","author":"H Daoudi","year":"2024","unstructured":"Daoudi H, Torres R, Mosnier I, Ambert-Dahan E, Liagre-Cailles A, Smail M, Nguyen Y, Ferrary E, Sterkers O, Lahlou G, Kalamarides M (2024) Long-term analysis of ABI auditory performance in patients with neurofibromatosis type 2-related schwannomatosis. Acta Neurochir (Wien) 166(1):390. https:\/\/doi.org\/10.1007\/s00701-024-06243-3","journal-title":"Acta Neurochir (Wien)"},{"key":"522_CR26","doi-asserted-by":"publisher","unstructured":"Dornhoffer JR, Plitt AR, Lohse CM, Driscoll CLW, Neff BA, Saoji AA, Van Gompel JJ, Link MJ, Carlson ML (2024) Comparing speech recognition outcomes between conchlear implants and auditory brainstem implants in patients with NF2-related schwannomatosis. Otol Neurotol. 1;45(1):29\u201335. https:\/\/doi.org\/10.1097\/MAO.0000000000004047","DOI":"10.1097\/MAO.0000000000004047"},{"issue":"5","key":"522_CR27","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3171\/2020.3.JNS192382","volume":"134","author":"S Abi Jaoude","year":"2020","unstructured":"Abi Jaoude S, Peyre M, Degos V, Goutagny S, Parfait B, Kalamarides M (2020) Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients. J Neurosurg 134(5):1377\u20131385. https:\/\/doi.org\/10.3171\/2020.3.JNS192382","journal-title":"J Neurosurg"},{"issue":"8","key":"522_CR28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/neuonc\/nos129","volume":"14","author":"S Goutagny","year":"2012","unstructured":"Goutagny S, Bah AB, Henin D, Parfait B, Grayeli AB, Sterkers O, Kalamarides M (2012) Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro Oncol 14(8):1090\u20131096. https:\/\/doi.org\/10.1093\/neuonc\/nos129","journal-title":"Neuro Oncol"},{"issue":"1","key":"522_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00401-024-02791-1","volume":"148","author":"Y Teranishi","year":"2024","unstructured":"Teranishi Y, Yurchenko A, Tran S, Sievers P, Rajabi F, Ruchith S, Abi-Jaoude S, Blouin A, Bielle F, Cazals-Hatem D, Sahm F, Nikolaev S, Kalamarides M, Peyre M (2024) Correlation between natural history and multi-omics profiling of meningiomas in NF2-related schwannomatosis suggests role of methylation group and immune microenvironment in tumor growth rate. Acta Neuropathol 148(1):30. https:\/\/doi.org\/10.1007\/s00401-024-02791-1","journal-title":"Acta Neuropathol"},{"issue":"5","key":"522_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00701-012-1590-z","volume":"155","author":"R Aboukais","year":"2013","unstructured":"Aboukais R, Baroncini M, Zairi F, Bonne NX, Schapira S, Vincent C, Lejeune JP (2013) Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients. Acta Neurochir (Wien) 155(5):771\u2013777. https:\/\/doi.org\/10.1007\/s00701-012-1590-z","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"522_CR31","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3171\/2024.7.SPINE24607","volume":"42","author":"NLA Nawabi","year":"2024","unstructured":"Nawabi NLA, Chalif JI, Renauld S, Mehta NH, Jha R, Gerstl JVE, Chalif E, Gupta S, Chi JH (2024) Presenting characteristics and clinical outcomes of idiopathic versus neurofibromatosis type 2-associated spinal meningiomas: a retrospective institutional experience. J Neurosurg Spine 42(2):238\u2013247. https:\/\/doi.org\/10.3171\/2024.7.SPINE24607","journal-title":"J Neurosurg Spine"},{"issue":"1","key":"522_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3171\/2015.3.SPINE141145","volume":"24","author":"P Li","year":"2016","unstructured":"Li P, Zhao F, Zhang J, Wang Z, Wang X, Wang B, Yang Z, Yang J, Gao Z, Liu P (2016) Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis type 2: a retrospective study at a single institution. J Neurosurg Spine 24(1):145\u2013154. https:\/\/doi.org\/10.3171\/2015.3.SPINE141145","journal-title":"J Neurosurg Spine"},{"issue":"2","key":"522_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11060-022-04061-0","volume":"159","author":"I Gugel","year":"2022","unstructured":"Gugel I, Grimm F, Tatagiba M, Schuhmann MU, Zipfel J (2022) Management of neurofibromatosis type 2 and schwannomatosis associated peripheral and intraspinal schwannomas: influence of surgery, genetics, and localization. J Neurooncol 159(2):271\u2013279. https:\/\/doi.org\/10.1007\/s11060-022-04061-0","journal-title":"J Neurooncol"},{"issue":"2","key":"522_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1227\/neu.0000000000002202","volume":"92","author":"M Peyre","year":"2023","unstructured":"Peyre M, Tran S, Parfait B, Bernat I, Bielle F, Kalamarides M (2023) Surgical management of peripheral nerve pathology in patients with neurofibromatosis type 2. Neurosurgery 92(2):317\u2013328. https:\/\/doi.org\/10.1227\/neu.0000000000002202","journal-title":"Neurosurgery"},{"issue":"4","key":"522_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3171\/2010.11.SPINE10350","volume":"14","author":"SR Plotkin","year":"2011","unstructured":"Plotkin SR, O\u2019Donnell CC, Curry WT, Bove CM, MacCollin M, Nunes FP (2011) Spinal ependymomas in neurofibromatosis type 2: a retrospective analysis of 55 patients. J Neurosurg Spine 14(4):543\u2013547. https:\/\/doi.org\/10.3171\/2010.11.SPINE10350","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"522_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11060-017-2690-7","volume":"136","author":"M Kalamarides","year":"2018","unstructured":"Kalamarides M, Essayed W, Lejeune JP, Aboukais R, Sterkers O, Bernardeschi D, Peyre M, Lloyd SK, Freeman S, Hammerbeck-Ward C, Kellett M, Rutherford SA, Evans DG, Pathmanaban O, King AT (2018) Spinal ependymomas in NF2: a surgical disease? J Neurooncol 136(3):605\u2013611. https:\/\/doi.org\/10.1007\/s11060-017-2690-7","journal-title":"J Neurooncol"},{"issue":"2","key":"522_CR37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11060-015-1925-8","volume":"125","author":"WI Essayed","year":"2015","unstructured":"Essayed WI, Bernard A, Kalamarides M (2015) Clinical response associated with radiographic regression of a cervicomedullary ependymoma in a NF2 patient treated by bevacizumab. J Neurooncol 125(2):445\u2013446. https:\/\/doi.org\/10.1007\/s11060-015-1925-8","journal-title":"JNeurooncol"},{"issue":"6","key":"522_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/ane.12490","volume":"133","author":"S Farschtschi","year":"2016","unstructured":"Farschtschi S, Merker VL, Wolf D, Schuhmann M, Blakeley J, Plotkin SR, Hagel C, Mautner VF (2016) Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2. Acta Neurol Scand 133(6):475\u2013480. https:\/\/doi.org\/10.1111\/ane.12490","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"522_CR39","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s00381-020-04729-w","volume":"36","author":"I Gugel","year":"2020","unstructured":"Gugel I, Grimm F, Teuber C, Zipfel J, Tatagiba M, Mautner VF, Schuhmann MU, Kluwe L (2020) Presenting symptoms in children with neurofibromatosis type 2. Childs Nerv Syst 36(10):2463\u20132470. https:\/\/doi.org\/10.1007\/s00381-020-04729-w","journal-title":"Childs Nerv Syst"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00522-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00522-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00522-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T05:02:06Z","timestamp":1766206926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00522-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00522-3","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}